Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Xinjin Gu"'
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-5 (2019)
Abstract Background Purpose of this study was to analyze whether preoperative maximum standardized uptake value (SUVmax) and carbohydrate antigen 19–9 (CA19–9) levels might provide prognostic information in Chinese patients with pancreatic duct a
Externí odkaz:
https://doaj.org/article/57f40f402f5f4a73be117c23a8c28f7f
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-5 (2019)
BMC Cancer
BMC Cancer
Background Purpose of this study was to analyze whether preoperative maximum standardized uptake value (SUVmax) and carbohydrate antigen 19–9 (CA19–9) levels might provide prognostic information in Chinese patients with pancreatic duct adenocarci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9cd602ec9df07a2f804c699ca37ac5c
http://link.springer.com/article/10.1186/s12885-019-5691-4
http://link.springer.com/article/10.1186/s12885-019-5691-4
Autor:
Yanan Zhang, Chengjian Guan, Jie Liu, Zhenyu Chang, Qinong Ye, Xinjin Gu, Rong Liu, Lihua Ding, Zelong Yang
Publikováno v:
Journal of Oncology
Journal of Oncology, Vol 2019 (2019)
Journal of Oncology, Vol 2019 (2019)
Gemcitabine-based chemotherapy is the first-line treatment for pancreatic cancer. However, chemoresistance is a major obstacle to drug efficacy, leading to poor prognosis. Little progress has been achieved although multiple mechanisms are investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27753fcfc4b8d55c03708364651e1c41
https://doi.org/10.1155/2019/9474273
https://doi.org/10.1155/2019/9474273
Autor:
Chen Wang, Xidong Ma, Rong Liu, Hui Deng, Lei Pan, Xinjin Gu, Sanhong Liu, Yuxia Liu, Xinying Xue, Xuelei Zang, Zhi-qiang Xue
Publikováno v:
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy, Vol 5, Iss 1, Pp 1-3 (2020)
Signal Transduction and Targeted Therapy, Vol 5, Iss 1, Pp 1-3 (2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60365e65671b8fc1f85347147eb356d1
https://doi.org/10.1038/s41392-020-0162-6
https://doi.org/10.1038/s41392-020-0162-6
Publikováno v:
Acta biochimica et biophysica Sinica. 52(5)
Cholangiocarcinoma (CCA) and gallbladder carcinoma (GBC) are biliary tract cancers with poor five-year survival and high recurrence rates. Both CCA and GBC patients suffer from lack of circulating diagnostic biomarkers at the early stage. Extracellul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1324176db4705d4059ca0de3b44edad
https://pubmed.ncbi.nlm.nih.gov/32369104
https://pubmed.ncbi.nlm.nih.gov/32369104
Publikováno v:
Biochemical and biophysical research communications. 515(1)
Discerning oncogenic drivers from passengers remains a major effort in understanding of the essence of the initiation and development of hepatocellular carcinoma (HCC), the most common primary liver malignancy and the third leading cause of cancer mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7b67888141de6b6e2ca6b8d22e5767f
https://pubmed.ncbi.nlm.nih.gov/31128910
https://pubmed.ncbi.nlm.nih.gov/31128910
Publikováno v:
Clinical Interventions in Aging
Xinjin Gu,1Rong Liu2 1Department of Hepatobiliary Surgery, Chinese People’s Liberation Army General Hospital and Hainan Branch, Sanya, 2Department of Hepatobiliary and Pancreatic Surgical Oncology, Chinese People’s Liberation Army General Hospita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d88245ec63d6f5ff673e88cffce60b0
http://europepmc.org/articles/PMC5047721
http://europepmc.org/articles/PMC5047721
Publikováno v:
Oncology Letters
Pancreatic cancer is one of the most life-threatening malignancies worldwide. Despite advances in checkpoint immunotherapy for patients with cancer, the current immunotherapies have demonstrated limited benefits for the treatment of pancreatic cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bb38994030ca20bf3eb0d30c9fcb973
https://doi.org/10.3892/ol.2020.12239
https://doi.org/10.3892/ol.2020.12239
Publikováno v:
Oncogene. 39:2844-2844
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::710178cb079afe9a5fa0b2e6b7feb45b
https://doi.org/10.1038/s41388-020-1180-0
https://doi.org/10.1038/s41388-020-1180-0
Autor:
Bo Tang, Guangying Qi, Xiaoyu Sun, Fang Tang, Shengguang Yuan, Zhenran Wang, Xingsi Liang, Bo Li, Shuiping Yu, Jie Liu, Qi Huang, Yangchao Wei, Run Zhai, Biao Lei, Xinjin Guo, Songqing He
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/35de9e8106904f77b92e36a4bae537d3